A fifth Covid vaccine has been approved by UK regulators and could be used as a booster jab next winter.
The jab, made by manufacturer Novavax, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) after safety, quality and effectiveness tests.
Whether it should be offered here and to which patient groups will now be considered by the Joint Committee on Immunisation and Vaccination (JCVI).
